Jonathan Carr
Overview
Explore the profile of Jonathan Carr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
893
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Groenewald K, Warwick J, Dupont P, Ackerman J, Amsterdam O, Carr J
Mov Disord Clin Pract
. 2024 Dec;
PMID: 39670503
Background: Rapid eye movement sleep behavior disorder (RBD) is an established prodrome and symptom of synucleinopathies. The pathophysiology of this disorder has been well studied but there is a lack...
2.
Jin Y, Li F, Li Z, Ikezu T, OLeary J, Selvaraj M, et al.
Sci Adv
. 2024 Sep;
10(37):eadk3700.
PMID: 39259788
Aggregated α-synuclein (α-SYN) proteins, encoded by the gene, are hallmarks of Lewy body disease (LBD), affecting multiple brain regions. However, the specific mechanisms underlying α-SYN pathology in cortical neurons, crucial...
3.
Landoulsi Z, Ashok Kumar Sreelatha A, Schulte C, Bobbili D, Montanucci L, Leu C, et al.
medRxiv
. 2024 Sep;
PMID: 39228715
Objective: Our study investigates the impact of copy number variations (CNVs) on Parkinson's disease (PD) pathogenesis using genome-wide data, aiming to uncover novel genetic mechanisms and improve the understanding of...
4.
Henning F, Naidu K, Record C, Dominik N, Vandrovcova J, Lubbe F, et al.
Mov Disord Clin Pract
. 2024 Aug;
11(10):1298-1300.
PMID: 39092477
No abstract available.
5.
Domenighetti C, Sugier P, Ashok Kumar Sreelatha A, Schulte C, Grover S, Portugal B, et al.
Neurology
. 2024 Jul;
103(3):e209620.
PMID: 38986057
Background And Objectives: The role of body mass index (BMI) in Parkinson disease (PD) is unclear. Based on the Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in PD...
6.
Narotam-Jeena H, Guttman M, van Hillegondsberg L, van Coller R, Krause A, Carr J
Mov Disord Clin Pract
. 2024 May;
11(7):850-854.
PMID: 38725192
Background: Huntington disease-like 2 (HDL2) is a neurodegenerative disorder, affecting only individuals of African ancestry. Full penetrance occurs in individuals with 40 repeats or more. Objective: To describe the phenotypic...
7.
Kerestes R, Laansma M, Owens-Walton C, Perry A, van Heese E, Al-Bachari S, et al.
Mov Disord
. 2023 Nov;
38(12):2269-2281.
PMID: 37964373
Background: Increasing evidence points to a pathophysiological role for the cerebellum in Parkinson's disease (PD). However, regional cerebellar changes associated with motor and non-motor functioning remain to be elucidated. Objective:...
8.
Hemmings S, Swart P, Womersely J, Ovenden E, van den Heuvel L, McGregor N, et al.
Discov Ment Health
. 2023 Oct;
2(1):6.
PMID: 37861850
Evidence suggests that shared pathophysiological mechanisms in neuropsychiatric disorders (NPDs) may contribute to risk and resilience. We used single-gene and network-level transcriptomic approaches to investigate shared and disorder-specific processes underlying...
9.
Gadama Y, Du Preez M, Carr J, Theron S, Albertyn C, Ssebambulidde K, et al.
J Med Case Rep
. 2023 Oct;
17(1):457.
PMID: 37845760
Background: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently described autoimmune inflammatory disorder of the central nervous system (CNS). There is limited data on the association between Human Immunodeficiency...
10.
Vollstedt E, Madoev H, Aasly A, Ahmad-Annuar A, Al-Mubarak B, Alcalay R, et al.
PLoS One
. 2023 Oct;
18(10):e0292180.
PMID: 37788254
Parkinson's disease (PD) is the fastest-growing neurodegenerative disorder, currently affecting ~7 million people worldwide. PD is clinically and genetically heterogeneous, with at least 10% of all cases explained by a...